Español

Authors

  • Español
  • Español
  • Español

Keywords:

Español

Abstract

On analyse the Spanish pharmaceutical market offer to cover the,. gastroesofagic reflux disease (GERD) therapy in paediatric population. A review of the pharmaceutical specialities corresponding to the groups A03AF, A02BA, and A02BC from the Specialities Catalogue of the Pharmaceutical College General Council attending to: Paediatric dosage and Pharmaceutical form this drugs are presento In the 44 % drugs in volved in GERD therapy specific paediatric studies aren't fit for use. The 33% of AH2 and 40% of IBP are usable in children. Any IBP has a correctly design presentation for paediatric population. On conclude that actual market hasn't correctly design medicines of the more effective therapies in the GERD treatment.

Downloads

Download data is not yet available.

Published

2003-12-20

How to Cite

1.
Español, Español, Español. Español. Ars Pharm [Internet]. 2003 Dec. 20 [cited 2024 May 18];45(1):73-80. Available from: https://revistaseug.ugr.es/index.php/ars/article/view/24723

Issue

Section

Special Articles